Madison, WI — 10 November 2021 – Imbed Biosciences, Inc. announced today that it has been awarded a contract for $1,999,481 by the U.S. Army Medical Research and Development Command’s
Read More from Imbed Biosciences Wins a $2M Award From the U.S. Army to Prevent Combat Wound Infections
Surgical Site Infection: Explained
WoundSource has put out an article explaining the reasons and difficulties of surgical site infections. The article includes explanations of epidemiology and risk factors as well as what needs to
Read More from Surgical Site Infection: Explained
NIH Awards Imbed Biosciences $800K SBIR Grant to Kill Bacteria in Biofilms
Madison, WI, October 14th, 2021 – Imbed Biosciences, Inc. (Imbed) announced today that it has been awarded $800,000 in a Commercialization Readiness Pilot (CRP) grant by the National Institute for
Read More from NIH Awards Imbed Biosciences $800K SBIR Grant to Kill Bacteria in Biofilms
Diabetic Foot Complication Research
The National Institutes of Health’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has formed the first ever network of six research institutions to study diabetic foot ulcers.
Read More from Diabetic Foot Complication Research
Microlyte® Matrix and Microlyte® Surgical featured in clinical research presented at SAWC
Madison, WI, October 12th, 2021 – Imbed Biosciences is proud to announce that research conducted using Microlyte Matrix and Microlyte Surgical will be presented in a panel discussion at SAWC,
Read More from Microlyte® Matrix and Microlyte® Surgical featured in clinical research presented at SAWC
Microlyte Surgical to be featured in upcoming edition of WOUNDS
Positive outcomes related to Imbed Bioscience’s product Microlyte Surgical will be featured in an upcoming edition of WOUNDS magazine. Ryan Chatelain, DPM, Associate Professor with the Department of Surgery in
Read More from Microlyte Surgical to be featured in upcoming edition of WOUNDS
Microlyte® SURGICAL Associated with Positive Outcomes in Prospective Clinical Case Series in Patients at Risk for Surgical Site Infection
Madison, WI, October 4, 2021 – Imbed Biosciences, Inc. (Imbed), a privately held biotech company emerging as a leader in advanced wound care, announced today the results of a prospective
Read More from Microlyte® SURGICAL Associated with Positive Outcomes in Prospective Clinical Case Series in Patients at Risk for Surgical Site Infection
Imbed Biosciences participates in The Ride
Cancer has affected us all in some direct or indirect way. Imbed is committed to help all cancer patients win that fight. The Ride occurs on Sunday, September 26 at
Read More from Imbed Biosciences participates in The Ride
HMP Global announces keynote speaker for SAWC Fall
The organizer’s of SAWC Fall 2021, HMP Global, have announced the keynote speaker for this year’s event. It is none other than internationally renowned fetal pediatric surgeon Oluyinka Olutoye, MD,
Read More from HMP Global announces keynote speaker for SAWC Fall